Hypoxia‐induced vascular endothelial growth factor expression causes vascular leakage in the brain

Formation of cerebral oedema caused by vascular leakage is a major problem in various injuries of the CNS, such as stroke, head injury and high‐altitude illness. A common feature of all these disorders is the fact that they are associated with tissue hypoxia. Hypoxia has therefore been suggested to be an important pathogenic factor for the induction of vascular leakage in the brain. Vascular endothelial growth factor (VEGF) is known as the major inducer of angiogenesis. Originally, however, it was described as a vascular permeability factor. As VEGF gene expression was shown to be upregulated by hypoxia, increased VEGF expression may link hypoxia and vascular leakage in the CNS in vivo. To delineate the role of VEGF in vascular leakage in the brain, we studied the effect of hypoxia on VEGF expression and vascular permeability in the brains of mice in vivo. Hypoxic exposure led to a significant increase in the levels of VEGF mRNA and protein in mouse brain that correlated with the severity of the hypoxic stimulus. Measurement of vascular permeability using the fluorescent marker sodium fluorescein revealed a two‐fold increase in fluorescence intensity in hypoxic brains, indicative of significant vascular leakage. Inhibition of VEGF activity by a neutralizing antibody completely blocked the hypoxia‐induced increase in vascular permeability. In conclusion, our data show that VEGF is responsible for hypoxia‐induced augmentation in vascular leakage following tissue hypoxia. Our findings might provide the basis for new therapeutic concepts for the treatment of cerebral oedem

Unusual activation pathways of amines in the reactions with molybdenum pentachloride

The 1-:-1 molar reactions at room temperature of MoCl5 with aliphatic amines were investigated in dichloromethane. Pyrrolidine, diethylamine and dibenzylamine underwent dehydrogenative oxidation when allowed to react with MoCl5; the compounds [MoCl5NCH(CH2)3], 1, and [CH3CHNHEt][MoOCl4], 2, were isolated in moderate to low yields from MoCl5/pyrrolidine and MoCl5/NHEt2, respectively. The chloride-amide complex [MoCl4(NEt2)], 3, was afforded in 65% yield from MoCl5 and Et2NSiMe3. The interaction of MoCl5 with Me2NSiMe3 was accompanied by activation of the solvent, and the complexes [MoCl3(NMe2)(κ2-Me2NCH2NMe2)], 4a, and [MoCl3(NMe)(κ2-Me2NCH2NMe2)], 4b, co-crystallized from the reaction mixture. The reactions of MoCl5 with a series of primary amines afforded mixtures of products, and the Mo(vi) chloride imido complexes [MoCl4(NR)]2 (R = Cy, 5a; tBu, 5b) were isolated in ca. 40% yield from MoCl5/NH2R (R = Cy, tBu). C-H bond activation may be viable in the reactions of MoCl5 with tertiary amines: the compounds [(CH2Ph)2NCHPh]2[MoCl6]·CH2Cl2, 6, and [NHEt3]2[Mo2Cl10], 7, were obtained from MoCl5/tribenzylamine and MoCl5/triethylamine, respectively. Pyrrolidine and tribenzylamine underwent analogous activation pathways when allowed to react with [MoCl3OCH(CF3)2]2 in the place of MoCl5. The isolated metal products were characterized by analytical and spectroscopic techniques, in addition the structures of 1, 2, 4, 5a, 6·CH2Cl2 and 7 were ascertained by single crystal X-ray diffraction studies. The organic products were identified by NMR and GC-MS after hydrolysis of the reaction mixtures. DFT calculations were carried out in order to assist the IR assignments, and clarify structural and mechanistic aspects

Tethering Carbohydrates to the Vinyliminium Ligand of Antiproliferative Organometallic Diiron Complexes

Four propargyl O-glycosides derivatized with mannose, glucose, and fructose moieties were synthesized and then incorporated within a diiron structure as part of a vinyliminium ligand. Hence, six glycoconjugated diiron complexes, [2−5]CF3SO3 (see Scheme 1) and the nonglycosylated analogues [6a−b]CF3SO3, were obtained in high yields and unambiguously characterized by elemental analysis, mass spectrometry, and IR and multinuclear NMR spectroscopies. All compounds exhibited a significant stability in DMSO-d6/D2O solution, with 63−89% of the complexes unaltered after 72 h at 37 °C and also in the cell culture medium. The cytotoxicity of [2−6]CF3SO3, as well as that of previously reported 7 and 8, was assessed on CT26 (mouse colon carcinoma), U87 (humanglioblastoma), MCF-7 human breast adenocarcinoma), and RPE-1 (human normal retina pigmented epithelium) cell lines. In general, the IC50 values correlate with the hydrophobicity of the compounds (measured as octanol−water partition coefficients) and do not show an appreciable level of selectivity against cancer cells with respect to the nontumor ones

Analysis of shared heritability in common disorders of the brain

ience, this issue p. eaap8757 Structured Abstract INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological comorbidity, inciting debate about their etiologic overlap. However, detailed study of phenotypes with different ages of onset, severity, and presentation poses a considerable challenge. Recently developed heritability methods allow us to accurately measure correlation of genome-wide common variant risk between two phenotypes from pools of different individuals and assess how connected they, or at least their genetic risks, are on the genomic level. We used genome-wide association data for 265,218 patients and 784,643 control participants, as well as 17 phenotypes from a total of 1,191,588 individuals, to quantify the degree of overlap for genetic risk factors of 25 common brain disorders. RATIONALE Over the past century, the classification of brain disorders has evolved to reflect the medical and scientific communities' assessments of the presumed root causes of clinical phenomena such as behavioral change, loss of motor function, or alterations of consciousness. Directly observable phenomena (such as the presence of emboli, protein tangles, or unusual electrical activity patterns) generally define and separate neurological disorders from psychiatric disorders. Understanding the genetic underpinnings and categorical distinctions for brain disorders and related phenotypes may inform the search for their biological mechanisms. RESULTS Common variant risk for psychiatric disorders was shown to correlate significantly, especially among attention deficit hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder (MDD), and schizophrenia. By contrast, neurological disorders appear more distinct from one another and from the psychiatric disorders, except for migraine, which was significantly correlated to ADHD, MDD, and Tourette syndrome. We demonstrate that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine. We also identify significant genetic sharing between disorders and early life cognitive measures (e.g., years of education and college attainment) in the general population, demonstrating positive correlation with several psychiatric disorders (e.g., anorexia nervosa and bipolar disorder) and negative correlation with several neurological phenotypes (e.g., Alzheimer's disease and ischemic stroke), even though the latter are considered to result from specific processes that occur later in life. Extensive simulations were also performed to inform how statistical power, diagnostic misclassification, and phenotypic heterogeneity influence genetic correlations. CONCLUSION The high degree of genetic correlation among many of the psychiatric disorders adds further evidence that their current clinical boundaries do not reflect distinct underlying pathogenic processes, at least on the genetic level. This suggests a deeply interconnected nature for psychiatric disorders, in contrast to neurological disorders, and underscores the need to refine psychiatric diagnostics. Genetically informed analyses may provide important "scaffolding" to support such restructuring of psychiatric nosology, which likely requires incorporating many levels of information. By contrast, we find limited evidence for widespread common genetic risk sharing among neurological disorders or across neurological and psychiatric disorders. We show that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures. Further study is needed to evaluate whether overlapping genetic contributions to psychiatric pathology may influence treatment choices. Ultimately, such developments may pave the way toward reduced heterogeneity and improved diagnosis and treatment of psychiatric disorders

The Anticancer Potential of Diiron Vinyliminium Complexes

The project focuses on the design, synthesis, and characterisation of new organometallic diiron complexes and on the evaluation of their potential as anticancer agents. In particular, the conjugation of the diiron core with organic molecules or metal fragments possessing a biological activity was considered, with the aim of studying the effect of the ligation of the two moieties on the anticancer efficacy. The experimental work included synthesis in solution, occasionally under an inert atmosphere, and analytical (via mass spectrometry), spectroscopic (via IR, NMR, UV-Vis), structural (via single-crystal XRD) and electrochemical (via CV and spectroelectrochemistry) characterisation of the compounds. Investigation of the stability and behaviour of the complexes in physiological media, assessment of in vitro cytotoxicity and more detailed biological studies, including cellular assays, were performed as well, in order to ascertain the activity and the mechanism of action

Synthesis and characterisation of organometallic diiron complexes with potential anticancer activity.

The main objectives of this thesis can be summarised as follows: 1. Synthesis and characterisation of new diiron vinyliminium complexes with variable substituents and of some related derivatives; 2. Evaluation of the in vitro antiproliferative activity of the complexes towards A2780, A2780R and HEK293 cell lines; 3. Study of the interaction of diiron vinyliminium complexes with biomolecules, with the aim of giving insight to their possible mechanism of action

Switching on Cytotoxicity of Water-Soluble Diiron Organometallics by UV Irradiation

: The diiron compounds [Fe2Cp2(CO)2(μ-CO)(μ-CSEt)]CF3SO3, [1]CF3SO3, K[Fe2Cp2(CO)3(CNCH2CO2)], K[2], [Fe2Cp2(CO)2(μ-CO)(μ-CNMe2)]NO3, [3]NO3, [Fe2Cp2(CO)2(PTA){μ-CNMe(Xyl)}]CF3SO3, [4]CF3SO3, and [Fe2Cp2(CO)(μ-CO){μ-η:1η3-C(4-C6H4CO2H)CHCNMe2}]CF3SO3, [5]CF3SO3, containing a bridging carbyne, isocyanoacetate, or vinyliminium ligand, were investigated for their photoinduced cytotoxicity. Specifically, the novel water-soluble compounds K[2], [3]NO3, and [4]CF3SO3 were synthesized and characterized by elemental analysis and IR and multinuclear NMR spectroscopy. Stereochemical aspects concerning [4]CF3SO3 were elucidated by 1H NOESY NMR and single-crystal X-ray diffraction. Cell proliferation studies on human skin cancer (A431) and nontumoral embryonic kidney (HEK293) cells, with and without a 10-min exposure to low-power UV light (350 nm), highlighted the performance of the aminocarbyne [3]NO3, nicknamed NIRAC (Nitrate-Iron-Aminocarbyne), which is substantially nontoxic in the dark but shows a marked photoinduced cytotoxicity. Spectroscopic (IR, UV-vis, NMR) measurements and the myoglobin assay indicated that the release of one carbon monoxide ligand represents the first step of the photoactivation process of NIRAC, followed by an extensive disassembly of the organometallic scaffold

Data publication: Switching on Cytotoxicity of Water-Soluble Diiron Organometallics by UV Irradiation

decarbonylation studies By IR, NMR, UV/vis myoglobin assay cell proliferation assay cristallographic data available by collaboration partne